SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Shukra Pharmaceuticals

BSE: 524632 29 Jun 2025
Healthcare
₹ 236
Shukra Pharmaceuticals Limited specializes in Pharmaceuticals within the Healthcare sector.

Shukra Pharmaceuticals - Share Price & Details

Market Cap
₹579.0
High /Low
27.2 / 5.75
Stock P/E
60.5
Book Value
₹1.44
Dividend Yield
0.76
ROCE
21.8
ROE
₹15.9
Face Value
1.0
PEG Ratio
0.25
EVEBITDA
₹33.8
Debt
4.17
CMP / FCF
-561.0
Debt to equity
₹0.07
NP Ann
9.58
High price all time
27.2
Piotroski score
₹5.0
Graham Number
2.66
No. Eq. Shares
43.8
Net CF
₹2.14
Net profit
9.58
Price to book value
9.22
Interest Coverage
₹23.6
Low price all time
0.01
Industry PE
32.0
Reserves
₹19.0
Free Cash Flow
₹5.18

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Shukra Pharmaceuticals LimitedNANANANA579.060.5
VENUS REMEDIES LTD.NANANANA57914.8
JENBURKT PHARMACEUTICALS LTD.NANANANA57417.9

Peer Comparison Chart


About Shukra Pharmaceuticals

Shukra Pharmaceuticals Limited, with Security Code 524632, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shukra Pharmaceuticals Faces Increased Selling Pressure Amid Significant Price Declines

(14 Jun 2025)
Shukra Pharmaceuticals Ltd is experiencing notable selling pressure, marking a shift after eight consecutive days of gains.
Read more →

Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y

(12 Jun 2025)
Net Sales at Rs 13.27 crore in March 2025 up 21.92% from Rs. 10.88 crore in March 2024. Story continues below Advertisement.
Read more →

Has Shukra Pharma. declared dividend?

(07 Jun 2025)
Yes, Shukra Pharmaceuticals Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of September 23, 2024. Despite recent periods showing...
Read more →

Shukra Pharmaceuticals Sees Strong Buying Activity Amid Price Gains and Market Resilience

(06 Jun 2025)
Shukra Pharmaceuticals Ltd is experiencing notable buying activity, with a significant increase in its stock price today. Despite a slight decline over the...
Read more →

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines

(05 Jun 2025)
Shukra Pharmaceuticals Ltd is experiencing significant selling pressure, marked by consecutive losses and a notable decline in its stock performance.
Read more →

BOARD OF SHUKRA PHARMACEUTICALS RECOMMENDS FINAL DIVIDEND

(04 Jun 2025)
Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 04 June 2025, has recommended a Final...
Read more →